COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 208 filers reported holding COHERUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $268,000 | -43.9% | 37,000 | 0.0% | 0.02% | -61.3% |
| Q1 2022 | $478,000 | -19.1% | 37,000 | 0.0% | 0.06% | -25.3% |
| Q4 2021 | $591,000 | -0.7% | 37,000 | 0.0% | 0.08% | -18.6% |
| Q3 2021 | $595,000 | +16.2% | 37,000 | 0.0% | 0.10% | -8.9% |
| Q2 2021 | $512,000 | -5.4% | 37,000 | 0.0% | 0.11% | -20.6% |
| Q1 2021 | $541,000 | -22.2% | 37,000 | -7.5% | 0.14% | -38.4% |
| Q4 2020 | $695,000 | -45.9% | 40,000 | -42.9% | 0.23% | -21.0% |
| Q3 2020 | $1,284,000 | -36.0% | 70,000 | -37.7% | 0.29% | -35.8% |
| Q2 2020 | $2,007,000 | +5.4% | 112,385 | -4.3% | 0.45% | +25.6% |
| Q1 2020 | $1,904,000 | -15.3% | 117,385 | -6.0% | 0.36% | +110.5% |
| Q4 2019 | $2,247,000 | -11.2% | 124,825 | 0.0% | 0.17% | +8.2% |
| Q3 2019 | $2,529,000 | – | 124,825 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |